Persistence and Fate of Invisible U/A Pairs in HIV-1 Proviral DNA
HIV-1 前病毒 DNA 中隐形 U/A 对的持久性和命运
基本信息
- 批准号:8910622
- 负责人:
- 金额:$ 15.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-11 至 2016-07-31
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAddressBase Excision RepairsBase PairingBiological AssayBiologyBiomedical ResearchCD4 Positive T LymphocytesCell LineCellsCommunitiesCouplingCytosineDNADNA IntegrationDNA SequenceDeaminationEnzymesExcisionGene ExpressionGene SilencingGenetic TranscriptionGenomeGenomicsHIVHIV InfectionsHIV-1HealthHighly Active Antiretroviral TherapyHumanImmuneImmune responseIn VitroInfectionInterphase CellInterventionLeadMapsMethodologyMethodsMolecularMutagenesisMutationNuclearNucleotidesPatientsPlayPopulationProvirusesRNA-Directed DNA PolymeraseReadingResolutionRestRoleRouteSpatial DistributionT-LymphocyteTimeUracilViralViral GenesViral GenomeViral Load resultVirusVirus DiseasesVirus LatencyWorkantiretroviral therapybasedeoxyuridine triphosphatedigitalgenome-widemacrophagenext generationnovelreactivation from latencyrepaireduracil-DNA glycosylaseviral DNA
项目摘要
DESCRIPTION (provided by applicant): A poorly understood molecular player in the intrinsic immune response against HIV is the simple nucleotide deoxyuridine triphosphate (dUTP). In non-replicating immune cells, dUTP levels are typically high, and upon HIV infection, viral reverse transcriptase incorporates dUTP into the nascent viral genome to generate U/A base pairs instead of the normal Watson-Crick T/A pairs. In the absence of nuclear uracil base excision repair (UBER) heavily uracilated viral DNA is fully competent for integration, but silences viral gene expression. Because UBER is virtually undetectable in resting cells, these findings indicate that uracilated proviruses will persist until a resting cell is activated. These considerations lead us to propose that persistent U/A base pairs play a previously unrecognized role in HIV-1 latency and reactivation. To characterize this aspect of HIV infection we will use a novel next-generation DNA sequencing method (BE-SEQ) to map the spatial distribution and temporal fate of "invisible" U/A base pairs in unintegrated and integrated HIV-1 DNA in a UBER-deficient cell line. High-resolution uracil mapping will provide valuable mechanistic information t understand how dUTP is incorporated into minus and plus strand DNA products by reverse transcriptase (RTase), and how its spatial distribution, persistence and possible error-prone removal may impact viral persistence in UBER-deficient immune cells. We will then determine the extent and persistence of uracil generated from dUTP incorporation or enzymatic cytosine deamination in proviral DNA obtained from resting CD4+ T cells of HIV-1 infected patients. These resting T cells will then be activated in vitro, and the fate of proviral uracils will be evaluated using a new trans-well viral outgrowth assay. Invisible uracils that silence viral gene transcription in the resting state could be repaired after reactivation, or instead, lead to lethal
genetic alterations by error prone repair mechanisms. Overall, these studies will determine the distribution, persistence and fate of U/A pairs in proviral DNA sequences and their potential effect on viral latency and infection.
描述(由申请人提供):在抗HIV的内在免疫应答中,一种了解不多的分子是简单的核苷酸脱氧尿苷三磷酸(dUTP)。在非复制型免疫细胞中,dUTP水平通常很高,并且在HIV感染后,病毒逆转录酶将dUTP掺入新生病毒基因组中以产生U/A碱基对而不是正常的沃森-克里克T/A对。在缺乏核尿嘧啶碱基切除修复(UBER)的情况下,严重尿嘧啶化的病毒DNA完全能够整合,但沉默病毒基因表达。由于UBER在静息细胞中几乎检测不到,这些发现表明尿嘧啶化前病毒将持续存在,直到静息细胞被激活。这些考虑使我们提出,持久的U/A碱基对发挥以前未被认识的作用,在HIV-1的潜伏期和再激活。为了表征HIV感染的这一方面,我们将使用新的下一代DNA测序方法(BE-SEQ)来绘制UBER缺陷细胞系中未整合和整合的HIV-1 DNA中“不可见”U/A碱基对的空间分布和时间命运。高分辨率尿嘧啶图谱将提供有价值的机制信息,以了解dUTP如何通过逆转录酶(RTase)并入负链和正链DNA产物,以及其空间分布,持久性和可能的易错去除如何影响病毒在UBER缺陷免疫细胞中的持久性。然后,我们将确定从HIV-1感染患者的静息CD 4 + T细胞获得的前病毒DNA中由dUTP掺入或酶促胞嘧啶脱氨基作用产生的尿嘧啶的程度和持久性。然后,这些静息T细胞将在体外被激活,并将使用新的trans-well病毒生长测定来评估前病毒尿嘧啶的命运。在静止状态下沉默病毒基因转录的隐形尿嘧啶可以在重新激活后修复,或者相反,导致致命的
通过易错修复机制的遗传改变。总体而言,这些研究将确定前病毒DNA序列中U/A对的分布、持久性和命运及其对病毒潜伏期和感染的潜在影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES T. STIVERS其他文献
JAMES T. STIVERS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES T. STIVERS', 18)}}的其他基金
Discovery of Chemical Probes of SAMHD1 for Modulation of Cancer Therapy and the Immune System
发现用于调节癌症治疗和免疫系统的 SAMHD1 化学探针
- 批准号:
10163140 - 财政年份:2020
- 资助金额:
$ 15.1万 - 项目类别:
Discovery of Chemical Probes of SAMHD1 for Modulation of Cancer Therapy and the Immune System
发现用于调节癌症治疗和免疫系统的 SAMHD1 化学探针
- 批准号:
10396629 - 财政年份:2020
- 资助金额:
$ 15.1万 - 项目类别:
Discovery of Chemical Probes of SAMHD1 for Modulation of Cancer Therapy and the Immune System
发现用于调节癌症治疗和免疫系统的 SAMHD1 化学探针
- 批准号:
10650716 - 财政年份:2020
- 资助金额:
$ 15.1万 - 项目类别:
Fate of Invisible U/A Base Pairs Within HIV DNA in Myeloid Phagocytic Cells
骨髓吞噬细胞中 HIV DNA 中看不见的 U/A 碱基对的命运
- 批准号:
9138025 - 财政年份:2016
- 资助金额:
$ 15.1万 - 项目类别:
Persistence and Fate of Invisible U/A Pairs in HIV-1 Proviral DNA
HIV-1 前病毒 DNA 中隐形 U/A 对的持久性和命运
- 批准号:
8790165 - 财政年份:2014
- 资助金额:
$ 15.1万 - 项目类别:
Purchase of a 600 MHz NMR Console and Probes
购买 600 MHz NMR 控制台和探头
- 批准号:
8051342 - 财政年份:2011
- 资助金额:
$ 15.1万 - 项目类别:
Fluorescence-Based Screen for Human DNA 5-Cytosine-methyltransferase 1
基于荧光的人类 DNA 5-胞嘧啶甲基转移酶 1 筛选
- 批准号:
8010339 - 财政年份:2010
- 资助金额:
$ 15.1万 - 项目类别:
Fluorescence-Based Screen for Human DNA 5-Cytosine-methyltransferase 1
基于荧光的人类 DNA 5-胞嘧啶甲基转移酶 1 筛选
- 批准号:
8089372 - 财政年份:2010
- 资助金额:
$ 15.1万 - 项目类别:
High Throughput Assay:Topoisomerase Enzyme Targets (RMI)
高通量检测:拓扑异构酶靶标 (RMI)
- 批准号:
7022489 - 财政年份:2005
- 资助金额:
$ 15.1万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 15.1万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 15.1万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 15.1万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 15.1万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 15.1万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 15.1万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 15.1万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 15.1万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 15.1万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 15.1万 - 项目类别:
Research Grant